DB-001 (DotBio)

N/A

Report date: 2022/11/14 16:03:40

Base Information

Drug NameDB-001 (DotBio)

Drug Alias NameDB-001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsProgrammed death-ligand 1 blockers

TargetsReceptor protein-tyrosine kinase erbB-2Programmed death-ligand 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDotbio Pte Ltd

China Registration ClassN/A

Develop Information

Active CompaniesDotbio Pte Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A